Intrinsic Value of S&P & Nasdaq Contact Us

Ecovyst Inc. ECVT NYSE

NYSE • Basic Materials • Chemicals - Specialty • US • USD

SharesGrow Score
29/100
0/7 Pass
SharesGrow Intrinsic Value
$51.35
+265%
Analyst Price Target
$9.67
-31.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ecovyst Inc. (ECVT) has a negative trailing P/E of -20.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 23.4 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -4.81%, forward earnings yield 4.28%. PEG 1.27.

Criteria proven by this page:

  • VALUE (10/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -20.8); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -4.81%); analyst consensus target implies downside from the current price ($9.67, 31.3%).
  • Forward P/E 23.4 — analysts expect a return to profitability with estimated EPS of $0.60 for FY2026.
  • PEG Ratio 1.27 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield -4.81% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 4.28% as earnings recover.
  • Analyst consensus target $9.67 (-31.3% downside) — analysts see meaningful downside risk at the current price level.

Overall SharesGrow Score: 29/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
29/100
SG Score
View full scorecard →
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
FUTURE
37/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
34/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ECVT

Valuation Multiples
P/E (TTM)-20.8
Forward P/E23.4
PEG Ratio1.27
Forward PEG1.27
P/B Ratio2.45
P/S Ratio1.94
EV/EBITDA11.4
Per Share Data
EPS (TTM)$-0.63
Forward EPS (Est.)$0.60
Book Value / Share$5.32
Revenue / Share$6.76
FCF / Share$0.62
Yields & Fair Value
Earnings Yield-4.81%
Forward Earnings Yield4.28%
Dividend Yield0.00%
SharesGrow IV$51.35 (+265%)
Analyst Target$9.67 (-31.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -16.9 0.02 1.32 1.26 -
2017 31.8 -0.21 1.12 1.24 2.41%
2018 33.9 -2.20 1.19 1.23 4.05%
2019 29.0 0.85 1.30 4.33 3.46%
2020 -6.9 0.02 1.51 3.90 12.61%
2021 -10.0 0.10 1.88 2.28 31.24%
2022 16.1 0.00 1.67 1.44 -
2023 16.3 1.06 1.64 1.67 -
2024 -134.1 1.22 1.27 1.27 -
2025 -15.8 -0.02 1.86 1.55 7.13%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-1.02 $1.06B $-79.75M -7.5%
2017 $0.52 $1.47B $57.6M 3.9%
2018 $0.43 $1.61B $58.3M 3.6%
2019 $0.59 $1.57B $79.5M 5.1%
2020 $0.40 $495.92M $54.28M 10.9%
2021 $0.01 $611.2M $1.8M 0.3%
2022 $0.52 $820.2M $73.7M 9%
2023 $0.60 $691.12M $71.15M 10.3%
2024 $-0.06 $704.49M $-6.65M -0.9%
2025 $-0.61 $723.5M $-71.1M -9.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.60 $0.57 – $0.62 $900.53M $899.41M – $901.64M 2
2027 $0.77 $0.76 – $0.77 $951.96M $948.69M – $957.37M 2
2028 $0.84 $0.84 – $0.85 $997M $995.75M – $998.25M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message